A CKD patient has metabolic acidosis with HCO3- 16 mEq/L. What is the first-line management?

Prepare for the HESI Chronic Kidney Disease Case Study Exam with multiple-choice questions and detailed explanations. Boost your confidence for success!

Multiple Choice

A CKD patient has metabolic acidosis with HCO3- 16 mEq/L. What is the first-line management?

Explanation:
Metabolic acidosis in CKD is treated by replacing the deficient bicarbonate to restore a normal acid-base balance. With a bicarbonate level at 16 mEq/L, the first-line step is oral bicarbonate therapy (usually sodium bicarbonate) to raise the level toward about 22–24 mEq/L. Correcting the acidosis can help slow CKD progression and improve bone and nutritional health. Dialysis is not the initial move unless acidosis is severe or unresponsive to medical therapy, and restricting bicarbonate or using potassium binders alone does not address the underlying acid-base disturbance. Start bicarbonate therapy and monitor response with follow-up labs, adjusting the dose to reach the target bicarbonate level.

Metabolic acidosis in CKD is treated by replacing the deficient bicarbonate to restore a normal acid-base balance. With a bicarbonate level at 16 mEq/L, the first-line step is oral bicarbonate therapy (usually sodium bicarbonate) to raise the level toward about 22–24 mEq/L. Correcting the acidosis can help slow CKD progression and improve bone and nutritional health. Dialysis is not the initial move unless acidosis is severe or unresponsive to medical therapy, and restricting bicarbonate or using potassium binders alone does not address the underlying acid-base disturbance. Start bicarbonate therapy and monitor response with follow-up labs, adjusting the dose to reach the target bicarbonate level.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy